Quest Laboratories (QUESTLAB.NS) Stock Price

Quest Laboratories Price

CLOSED
93.45
​
Market closed

Revenue has compounded at 29.9% per year over the past 2 years to 1.04 B INR. Earnings per share have grown at 64.3% per year over the last 2 years. Quest Laboratories's net margin stands at 13.0%, up from 8.2% several years earlier.

Quest Laboratories stock price

Access this data via the Eulerpool API

Quest Laboratories business model & stock analysis

Quest Laboratories Ltd is a IN-based company operating in Pharmaceuticals industry. The company is headquartered in Dhar, Madhya Pradesh. The company went IPO on 2024-05-23. Quest Laboratories Limited is engaged in the business of manufacturing pharmaceutical formulations across a broad spectrum, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more. The firm produces a variety of products, comprising ethical drugs, generic drugs, and over-the-counter drugs (OTC). These products are available in various forms, such as tablets, liquid orals, oral dry powders, oral powders (ORS), ointments, and external liquids. The tablets include Cetirizine Hydrochloride Tablet IP 10 mg, Zinc Sulphate Dispersible Tablet IP, Diclofenac Sodium Tablet BP, and others. The company offers dry syrup and suspension, such as Ferrous Sulphate & Folic Acid Syrup, Albendazole Suspension IP, Zinc Oral Solution USP, Alpha Amilase & Pepsine, Sucralfate Suspension, and others. Its ointments include Silver Sulphadiazine Cream IP, Diclofenac Diethylamino IP Gel, and others.

Frequently asked questions about Quest Laboratories

Converted at the current exchange rate, the Quest Laboratories share trades at 0.86 EUR (93.45 INR).

The revenue cannot currently be calculated for Quest Laboratories.

The profit cannot currently be calculated for Quest Laboratories.

The P/E ratio cannot be calculated for Quest Laboratories at the moment.

The P/S cannot be calculated for Quest Laboratories currently.

The Eulerpool Quality Score for Quest Laboratories is 2/10.

The ISIN of Quest Laboratories is INE0TNW01017. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Quest Laboratories is QUESTLAB.NS. The ticker symbol is used to trade Quest Laboratories shares on the stock exchange.

Fair ValueTerminal
95.32 INR
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Currency
INR
Initial public offering
May 23, 2024
ISIN
INE0TNW01017
Cusip
Y7S6GS106
Market capitalization
1.53 B INRSmall Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
11.95
P/B Ratio
1.87
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
12.11 %
Last updated Oct 9, 2026, 4:10 AM

Quest Laboratories Peer Group